Navigation Links
Studies Show Pterostilbene Shows Promise for Anti-Aging and Maintaining Healthy Brain
Date:1/9/2014

Houston, TX (PRWEB) January 09, 2014

With 1 in 3 seniors dying with Alzheimer’s or another dementia (source), scientists have long been fighting to find a way to preserve brain health as we age. Now, hope comes from a little-known compound found in blueberries called pterostilbene. In clinical studies, pterostilbene has shown promise as a treatment in the protection against age-related diseases, including Alzheimer’s disease.
In the September 2012 study published first in Neurobiology of Aging, researchers looked at mice that were genetically developed as a model of age-related cognitive decline. The mice were give two different compounds containing pterostilbene and resveratrol. The study found that pterostilbene was the most effective at positively affecting brain function. Now, researchers see hope that pterostilbene could offer the same brain-boosting benefits in humans.
The researchers said, “While it is yet to be determined whether the cognitive improvements induced by pterostilbene in the SAMP8 model can be applied to humans, recent reports demonstrate that fruits containing pterostilbene such as blueberries ameliorate cognitive function in aged humans.”

With so many positive cognitive enhancement benefits associated with pterostilbene, it’s no wonder many people are searching for ways to add more of this potent compound to their diet. It was even named one of the best nootropics by NootropicStack.net. A new memory enhancement supplement, Biohack Pure, features pterostilbene as a key ingredient.

“Based on all the research we’ve seen, pterostilbene is a highly effective antioxidant that fights free radicals and plays a key role in cognitive enhancement,” said Jonathan Weisman, president at Biohack Nutrition, makers of Biohack Pure. “We’re really excited for the potential of this berry compound at helping preserve brain health and preventing cognitive decline.”
For more information, visit http://www.BiohackPure.com.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11473898.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. S*BIOs Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF)
2. Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
3. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
4. Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
5. EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies
6. Novel compound halts tumor spread, improves brain cancer treatment in animal studies
7. Convergence Pharmaceuticals Announces Successful Completion of Phase I for CNV2197944 and Plans Phase II Studies in Neuropathic Pain
8. Karyopharm Therapeutics announces the Publication of Two Preclinical Studies on the Activity of Selective Inhibitors of Nuclear Export (SINE) in Acute Myeloblastic Leukemia (AML)
9. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
10. Genomic Health Announces Presentation of Six Studies at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium
11. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December 2016 ... extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) specific ... offer NAT screening for blood donors under an Investigational New Drug (IND) study protocol. ...
(Date:4/26/2017)... Pa. , April 26, 2017  Genisphere ... delivery platform, has signed a collaborative and sponsored ... Dr. Silvia Muro . The overall goal ... and pharmacodynamics of various 3DNA designs and formulations ... involve targeting diseases of the vasculature as well ...
(Date:4/25/2017)... Providence -based biotechnology ... technology to an undisclosed global pharmaceutical company, for ... Tregitopes, pronounced T·rej·itopes, are a set of peptides ... Annie De Groot and EpiVax CIO ... autoimmune disease therapy, Tregitopes are capable of engaging regulatory ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... denaturation in a cellular milieu; however, the broad application of this cellular target ... platforms with sensitive quantitative readouts. Cell-based thermal stabilization assays are valuable methods for ...
Breaking Biology Technology:
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel visited ... to the DERMALOG stand together with the Japanese Prime Minster Shinzo Abe. ... the largest German biometrics company the two government leaders could see the ... well as DERMALOG´s multi-biometrics system.   Continue Reading ... ...
(Date:3/9/2017)... Australia , March 9, 2017 /PRNewswire/ ... at the prestigious World Lung Imaging Workshop at the ... Fouras , was invited to deliver the latest data ... This globally recognised event brings together leaders at the ... latest developments in lung imaging. "The ...
Breaking Biology News(10 mins):